NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization233.19 mln
Float26.63 mln
Earnings Date05/07/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
14.56
Transformational upside
Relative Strength
82
/ 100
Strongly outperforming
Debt / Equity
0.69
Moderate leverage
ROE
-214
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Achieve Life Sciences is a pharmaceutical company based in Bothell, Washington, focused on helping people quit smoking. Its lead product, cytisinicline, is a naturally derived compound that works by targeting nicotine receptors in the brain, easing the discomfort of withdrawal. The company operates across the United States, Canada, and the United Kingdom, supported by agreements with Sopharma AD and the University of Bristol for licensing and supply.
